Chesapeake Capital Corp /Il/ Grifols Sa Transaction History
Chesapeake Capital Corp /Il/
- $98.5 Billion
- Q4 2024
A detailed history of Chesapeake Capital Corp /Il/ transactions in Grifols Sa stock. As of the latest transaction made, Chesapeake Capital Corp /Il/ holds 24,638 shares of GRFS stock, worth $240,220. This represents 0.19% of its overall portfolio holdings.
Number of Shares
24,638
Previous 16,500
49.32%
Holding current value
$240,220
Previous $148 Million
24.13%
% of portfolio
0.19%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding GRFS
# of Institutions
172Shares Held
153MCall Options Held
42.9KPut Options Held
82.4K-
Brandes Investment Partners, LP La Jolla, CA28MShares$273 Million2.4% of portfolio
-
Capital World Investors Los Angeles, CA21.7MShares$211 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.6MShares$182 Million32.54% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.6MShares$123 Million5.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.67MShares$94.3 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.62B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...